CN104211663B — 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用
Assigned to HANGZHOU OULIAN MEDICINE SCIENCE & TECHNOLOGY Co Ltd · Expires 2017-01-11 · 9y expired
What this patent protects
本发明公开了一种式(5)所示的(S)‑N‑甲氧基‑甲基‑2‑(四氢吡咯基)丙酰胺,其制备方法为:以L‑丙氨酸为起始原料,通过氨基保护、与N,O‑二甲基羟胺盐酸盐反应、脱除氨基保护基、烷基化四步反应制备得到;所得式(5)所示化合物再经加成消去、还原即得式(7)所示的依法韦伦手性配体;本发明中依法韦伦手性配体的合成方法具有反应条件温和、操作简便、收率高、生产成本低等优点,适合于工业化生产;
USPTO Abstract
本发明公开了一种式(5)所示的(S)‑N‑甲氧基‑甲基‑2‑(四氢吡咯基)丙酰胺,其制备方法为:以L‑丙氨酸为起始原料,通过氨基保护、与N,O‑二甲基羟胺盐酸盐反应、脱除氨基保护基、烷基化四步反应制备得到;所得式(5)所示化合物再经加成消去、还原即得式(7)所示的依法韦伦手性配体;本发明中依法韦伦手性配体的合成方法具有反应条件温和、操作简便、收率高、生产成本低等优点,适合于工业化生产;
Drugs covered by this patent
- Copiktra (DUVELISIB) · Secura
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.